Mike, joe;
I just read the 8-K and the 10-k reports in EDGAR, and was duly impressed.
"At September 30, 1996, the Company's current ratio was 7.6 to 1 compared to 4.8 to 1 at December 31, 1995. Cash provided by operating activities for the nine months ended September 30, 1996 was $2,420,855 as compared to $531,059 for the nine months ended September 30, 1995. At September 30, 1996 cash and cash equivalents on hand was 14,269,404 as compared to $1,393,092 at December 31, 1995."
I have not invested yet with this company, as I have more DD work to do. What i like is the fact that this company does not have to file with the FDA for approvals, as they are providers to other research companies.
according to their 8-k they have a web page at: biosource.com
will check that out
Frank |
